Clinical Trial Update: Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry

View source ↗

Summary

The SMART Registry, a study of minimally-invasive ablative renal therapies for renal cell carcinoma, is currently suspended. Sponsor is the University of Albert…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Alberta | Conditions: Renal Cancer | Status: SUSPENDED